CeCors, Inc.
CEOS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.41M
Close$
$0.00
64.4% downside
Current Fair Value
64.4% downsideOvervalued by 64.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.41 Million |
|---|---|
| Enterprise Value | $-1,157,159.00 |
| Earnings per Share | $0.01 |
| Beta | 0.33 |
| Outstanding Shares | 313,079,838 |
Return
| Return on Equity | -100.88% |
|---|---|
| Return on Assets | -45.75% |
| Return on Invested Capital | -91.39% |
Valuation & Multiples
| P/E Ratio | 0.49 |
|---|---|
| PEG | 0.13 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.51 |
| Enterprise Value to EBIT | 0.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CeCors, Inc.
6 employees
CEO: Michael Maher
CeCors, Inc. engages in the acquisition and development of healthcare companies focusing on military veterans. It operates through the PsyKey and VETCOMM segments. The PsyKey segment refers to consumer goods. It is related to the sales o...